Erratum: TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum

Theranostics. 2021 Jan 1;11(5):2079. doi: 10.7150/thno.56734. eCollection 2021.

Han-Li Huang^{1

2}, Yi-Min Liu¹, Ting-Yi Sung², Tsui-Chin Huang³, Ya-Wen Cheng³, Jing-Ping Liou^{1

4}, Shiow-Lin Pan^{1

2

3}

¹ TMU Biomedical Commercialization Center, Taipei Medical University, Taipei 11031, Taiwan.
² Ph.D Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
³ Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
⁴ School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.

Abstract

[This corrects the article DOI: 10.7150/thno.34020.].